Last reviewed · How we verify
NCT04998903
Change in Management Following Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates
trial testing Fiberoptic Bronchoscopy in Stem Cell Transplant Complications in 51 participants. Completed in 27 February 2020.
30 September 2019
Quick facts
| Lead sponsor | King Faisal Specialist Hospital & Research Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 51 |
| Start date | 1 May 2016 |
| Primary completion | 30 September 2019 |
| Estimated completion | 27 February 2020 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Fiberoptic Bronchoscopy
Conditions studied
- Stem Cell Transplant Complications — all drugs for Stem Cell Transplant Complications →
- Pulmonary Complication — all drugs for Pulmonary Complication →
Sponsor
King Faisal Specialist Hospital & Research Center
Who can join
14 and older, any sex, with Stem Cell Transplant Complications or Pulmonary Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hematopoietic stem cell transplant (HSCT) is a modality that is increasingly utilized to treat various haematological disorders with a varying degree of success. From 2006 to 2019 use of HSCT worldwide has increased from 50,417 to an estimated 1.5 million. Disease relapse, graft versus host disease (GVHD) and infections are the leading causes of morbidity and mortality in patients with HSCT. Pulmonary complications, in particular, are common in patients with HSCT, and the diagnostic approach and management of these complications remain a challenge. FOB is one of the standard and least invasive diagnostic modality for these patients. However, the diagnostic yield and change in clinical decision making in those studies have been variable. Furthermore, all these studies were retrospective, with one exception. The investigators designed an observational study to understand the rate of change in clinical decision making following Fiberoptic bronchoscopy (FOB). The investigators also looked at the yield of FOB and characteristics associated with a positive diagnostic yield.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04998903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fiberoptic Bronchoscopy
Trials testing the same drug.
- NCT07149909 — Fiberoptic Bronchoscopy in Severe Ventilator-associated Pneumonia · NA · completed
- NCT04872881 — Comparison of Effectiveness of Different Airway Management Methods During Percutaneous Tracheostomy · Phase 4 · unknown
Other recruiting trials for Stem Cell Transplant Complications
Currently open trials in the same condition.
- NCT07509749 — Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) · Phase 2 · recruiting
- NCT07340723 — Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease ) · Phase 2 · recruiting
- NCT06541002 — A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors · NA · recruiting
- NCT05421416 — Loratadine for the Prevention of G-CSF-related Bone Pain · Phase 2 · recruiting
- NCT06512545 — Modified Second Haplo-transplantation for Graft Failure · NA · recruiting
Other King Faisal Specialist Hospital & Research Center trials
Trials by the same sponsor.
- NCT07429929 — Saudi Emergency Laparotomy Audit · not yet recruiting
- NCT07324174 — A Randomized Controlled Trial on the Effectiveness of Early Versus Conservative Rehabilitation Following Rotator Cuff Re · NA · not yet recruiting
- NCT07316777 — Saudi CABG Audit and Registry · not yet recruiting
- NCT07318571 — AI-Assisted Skin Assessment for Pressure Injury Prevention in Critical Care Nurses · NA · recruiting
- NCT07243041 — Code Status Discussions in Muslim ICU Patients: Insights Into Physician-Family Communication · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04998903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Faisal Specialist Hospital & Research Center
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04998903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing